Blinded sample size re-estimation with unequal variances and center effects in clinical trials
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Communications in Statistics - Theory and Methods
- Vol. 27 (2) , 395-408
- https://doi.org/10.1080/03610929808832102
Abstract
The two-stage sample size re-estimation procedure developed previously in the literature (e.g.,Shih, 1992; Gould and Shih, 1992) treats the blinded data from a randomized clinical trial as a sample from a mixture of two normal distributions of equal variances.This paper investigates the procedure when being applied to the situations where the variances are unequal and blocking effects by clinical centers are present.We show by simulations that in both situations the re-estimation procedure is still capable to update the sample size properly for attaining the required power and preserving the type-1 error at the nominal level.Keywords
This publication has 10 references indexed in Scilit:
- Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of changeStatistics in Medicine, 1995
- Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP working party on efficacy of medicinal products note for guidance III/3630/92‐ENStatistics in Medicine, 1995
- Internal pilot studies for estimating sample sizeStatistics in Medicine, 1994
- Sample Size Reestimation for Triple Blind Clinical TrialsDrug Information Journal, 1993
- The Use of Interim Analysis for Sample Size AdjustmentDrug Information Journal, 1993
- Sample size determination using an interim analysisJournal of Biopharmaceutical Statistics, 1993
- Sample size re-estimation without unblinding for normally distributed outcomes with unknown varianceCommunications in Statistics - Theory and Methods, 1992
- Discussion of papers of session 3: Bayes/empirical bayesStatistics in Medicine, 1992
- The role of internal pilot studies in increasing the efficiency of clinical trialsStatistics in Medicine, 1990
- A Prospective, Randomized, Controlled Trial of Prednisone for Dilated CardiomyopathyNew England Journal of Medicine, 1989